CN115363058B - Disinfectant for effectively inactivating novel coronaviruses - Google Patents
Disinfectant for effectively inactivating novel coronaviruses Download PDFInfo
- Publication number
- CN115363058B CN115363058B CN202110810090.0A CN202110810090A CN115363058B CN 115363058 B CN115363058 B CN 115363058B CN 202110810090 A CN202110810090 A CN 202110810090A CN 115363058 B CN115363058 B CN 115363058B
- Authority
- CN
- China
- Prior art keywords
- parts
- disinfectant
- novel
- water
- ammonium chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000645 desinfectant Substances 0.000 title claims abstract description 79
- 241000711573 Coronaviridae Species 0.000 title claims abstract description 63
- 230000000415 inactivating effect Effects 0.000 title claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 43
- 108090000988 Lysostaphin Proteins 0.000 claims abstract description 36
- -1 compound quaternary ammonium chloride Chemical class 0.000 claims abstract description 24
- 239000001341 hydroxy propyl starch Substances 0.000 claims abstract description 24
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims abstract description 24
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims abstract description 23
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims abstract description 23
- 229960005233 cineole Drugs 0.000 claims abstract description 23
- 239000000419 plant extract Substances 0.000 claims abstract description 22
- 239000013543 active substance Substances 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000011259 mixed solution Substances 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 11
- 239000000341 volatile oil Substances 0.000 claims description 9
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 claims description 8
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 8
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 8
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 8
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 7
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 claims description 6
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 235000004443 Ricinus communis Nutrition 0.000 claims description 5
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 4
- 240000003553 Leptospermum scoparium Species 0.000 claims description 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 229940087603 grape seed extract Drugs 0.000 claims description 4
- 235000002532 grape seed extract Nutrition 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 4
- 235000005206 Hibiscus Nutrition 0.000 claims description 3
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims description 3
- 244000048199 Hibiscus mutabilis Species 0.000 claims description 3
- 238000000889 atomisation Methods 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims 2
- 235000003973 Hibiscus mutabilis Nutrition 0.000 claims 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 description 19
- 241000700605 Viruses Species 0.000 description 11
- 230000002779 inactivation Effects 0.000 description 11
- 230000001954 sterilising effect Effects 0.000 description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 230000003253 viricidal effect Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- XIWFQDBQMCDYJT-UHFFFAOYSA-M benzyl-dimethyl-tridecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 XIWFQDBQMCDYJT-UHFFFAOYSA-M 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 5
- 230000002045 lasting effect Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 230000000249 desinfective effect Effects 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000003501 vero cell Anatomy 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 241001678559 COVID-19 virus Species 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- 244000166124 Eucalyptus globulus Species 0.000 description 2
- 241000218033 Hibiscus Species 0.000 description 2
- 241000721662 Juniperus Species 0.000 description 2
- 108010013639 Peptidoglycan Proteins 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000003206 sterilizing agent Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 description 1
- 229930195715 D-glutamine Natural products 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MNLRQHMNZILYPY-MDMHTWEWSA-N N-acetyl-alpha-D-muramic acid Chemical group OC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]1NC(C)=O MNLRQHMNZILYPY-MDMHTWEWSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 101800000021 N-terminal protease Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000009972 noncorrosive effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000029305 taxis Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
- A01N25/06—Aerosols
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/24—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients to enhance the sticking of the active ingredients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/06—Oxygen or sulfur directly attached to a cycloaliphatic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/12—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/06—Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/18—Euphorbiaceae [Spurge family], e.g. ricinus [castorbean]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/28—Myrtaceae [Myrtle family], e.g. teatree or clove
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Pest Control & Pesticides (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The application discloses a novel disinfectant for effectively inactivating novel coronaviruses, which comprises the following raw materials in parts by weight: 20-32 parts of natural plant extract, 0.4-0.7 part of food-grade active agent, 2-3 parts of compound quaternary ammonium chloride, 0.2-0.4 part of lysostaphin, 3-5 parts of eucalyptol, 1-2 parts of hydroxypropyl starch and 58-64 parts of water, wherein the novel disinfectant is prepared by steps of multistage mixing, pH value adjustment and the like.
Description
Technical Field
The invention belongs to the technical field of disinfectant preparation, and particularly relates to a novel disinfectant for effectively inactivating novel coronaviruses, a preparation method and a use method thereof.
Background
Along with the global spread of new crown epidemic situation, disinfection is moved from a market segment to mass market, epidemic prevention disinfection is moved to normalization step by step.
The main types of disinfectants currently used in the market for killing new crowns are three main types:
1. chlorine-containing disinfectants, typically 84 disinfectants on the market, are most widely used due to low price;
2. peroxide disinfectants, hydrogen peroxide and peroxyacetic acid in the market are more used in the field of medical professional disinfection due to the advantage of strong oxidizing property;
3. alcohol disinfectant, which is typically 75% alcohol disinfectant in market, has reasonable price and better effect, and is more used in domestic markets such as household disinfection, hand disinfection and the like.
However, these disinfectants have limitations in terms of performance or application in the face of epidemic prevention in new crown epidemic situations:
the biggest disadvantage of 84 disinfectants is that the disinfectant is toxic and has strong oxidizing property, and chlorine generated after decomposition is toxic, and can only be used for disinfecting an open place, but cannot be used for disinfecting a closed space, such as an elevator cabin, and particularly cannot be used for disinfecting skin, mucous membranes, clothes, metal surfaces and other places. So 84 disinfectant is not usable in the strict sense of all articles that are directly sterilized by a person or in close contact with a person.
Peroxide disinfectants, most commonly hydrogen peroxide with concentration of 3% -5%, have strong irritation, corrosiveness and bleaching property, and hydrogen peroxide disinfectant with concentration of 0.5% can realize disinfection and sterilization of new coronavirus without obvious side effect, but the hydrogen peroxide disinfection technology with concentration of 0.5% and stability has higher difficulty and higher realization cost than the disinfectant of the invention, so that the peroxide disinfectant is more used for high-end disinfection application in operating rooms and the like.
The 75% alcohol disinfectant can be used for directly disinfecting human body or metal, and has the defects of irritation, flammability and allergen. If the fabric is electrostatically charged, it is extremely liable to cause a fire, and thus cannot be sprayed for sterilization. Taking an airplane, a high-speed railway and an automobile, the disinfectant containing alcohol is not allowed to be carried.
In the new epidemic situation, people, things and places need to be thoroughly disinfected, most disinfectants have various limitations, the combined use brings technical complexity and security holes in implementation, the cost is high, and a safe and broad-spectrum efficient disinfectant is urgently needed in the market.
Disclosure of Invention
The invention provides a novel disinfectant for effectively inactivating novel coronaviruses, a preparation method and a use method thereof, which are used for solving the problems of poor applicability of the existing disinfectant to inactivating novel coronaviruses and the like.
In order to solve the technical problems, the invention adopts the following technical scheme:
the novel disinfectant for effectively inactivating the novel coronavirus comprises the following raw materials in parts by weight: 20-32 parts of natural plant extract, 0.4-0.7 part of food-grade active agent, 2-3 parts of compound quaternary ammonium chloride compound, 0.2-0.4 part of lysostaphin, 3-5 parts of eucalyptol, 1-2 parts of hydroxypropyl starch and 58-64 parts of water.
Preferably, the novel disinfectant for effectively inactivating the novel coronavirus comprises the following raw materials in parts by weight: 28 parts of natural plant extract, 0.6 part of food-grade active agent, 2.4 parts of compound quaternary ammonium chloride compound, 0.3 part of lysostaphin, 4 parts of eucalyptol, 1.6 parts of hydroxypropyl starch and 60 parts of water.
Preferably, the natural plant extract comprises one or more of tea tree essential oil, eucalyptus essential oil, juniper essential oil, grape seed extract, castor extract and hibiscus extract.
Preferably, the food grade active agent comprises erucic acid.
Preferably, the compound quaternary ammonium chloride compound consists of cetylpyridinium chloride, didecyl dimethyl ammonium chloride and benzalkonium chloride according to the weight ratio of 2-4:5-7:1-2.
Preferably, the compound quaternary ammonium chloride compound consists of cetylpyridinium chloride, didecyl dimethyl ammonium chloride and benzalkonium chloride according to the weight ratio of 3:6.2:1.4.
Preferably, the water comprises one or more of distilled water, purified water, and fresh cool boiled water.
The invention also provides a preparation method of the novel disinfectant for effectively inactivating the novel coronavirus, which comprises the following steps:
s1: mixing natural plant extract, food-grade active agent and water, heating to 55-63deg.C, stirring at 200-300r/min for 7-10min to obtain mixed solution A;
s2: cooling the mixed solution A prepared in the step S1 to 32-45 ℃, adding a compound quaternary ammonium chloride compound, and stirring for 6-8min at the microwave power of 100-200W and the rotating speed of 300-400r/min to prepare mixed solution B;
s3: and (2) adding lysostaphin, eucalyptol and hydroxypropyl starch into the mixed solution B prepared in the step (S2), stirring for 5-6min at the temperature of 46-52 ℃ and the temperature of 200-300r/min under the pressure of 1-2MPa, and then regulating the pH value to obtain the novel disinfectant for effectively inactivating the novel coronavirus.
Preferably, the pH in step S3 is between 6 and 6.8.
The invention also provides a use method of the novel disinfectant for effectively inactivating the novel coronavirus, which comprises the steps of diluting the novel disinfectant to a mass concentration not lower than two parts per million by adopting one or more of distilled water, purified water and fresh cool boiled water, and then spraying the novel disinfectant into the air or onto the surface of an object in an atomization mode, so that the novel coronavirus can be effectively inactivated.
The invention has the following beneficial effects:
1. the invention utilizes the stability of the protein capsid interfering the surface of the novel coronavirus contained in the natural plant extract to achieve the killing effect, and utilizes the surfactant property of the quaternary ammonium salt compound to destroy the lipid layer on the surface of the novel coronavirus so as to lose various composite killing effects such as the infection capability to human cells.
2. The lysostaphin, the citrinol and the hydroxypropyl starch play a synergistic role in preparing the novel disinfectant disclosed by the invention, and the inactivation efficiency of the novel coronavirus is synergistically improved, because: the lysostaphin generates leakage holes by destroying proteins of cell membranes of the novel coronaviruses, so that normal functions of the viruses are interfered, nutrient loss of the novel coronaviruses is caused, and the novel coronaviruses die gradually, and the novel coronaviruses are matched with the citrinol for use, so that the citrinol can form a supermolecular stable structure with the lysostaphin, and the stability and lasting virucidal effect of the novel disinfectant are further improved; meanwhile, the eucalyptol has extremely strong virucidal capability, can change the potential of the virus surface, can enhance the penetration capability of lysostaphin, and further enhances the virucidal effect; the hydroxypropyl starch has good viscosity, and after the novel disinfectant disclosed by the invention is used, the novel disinfectant can be adhered to the surface of a novel coronavirus, so that interaction between the eucalyptol citrate and the lysostaphin is promoted, the lasting virucidal effect is enhanced, and the inactivation efficiency of the novel coronavirus is improved.
The specific action principle is as follows: staphylococcus aureus is a gram-positive bacterium, peptidoglycan is an important component of its cell wall, maintains cell morphology, and protects cells from osmotic swelling. Staphylococcus aureus peptidoglycans are composed of alternating N-acetylglucosamine and N-acetylmuramic acid residues, muramic acid is linked to tetrapeptides (D-alanine, D-glutamine, L-lysine, D-alanine) and tetrapeptides and glycine pentapeptides are linked together by epsilon-amino groups of single-chain lysine residues and on the other side by alanine carboxyl groups. Lysostaphin first synthesizes a preproenzyme of 493 amino acids, which is directed into the secretory pathway by a leader peptide of 36 amino acids at the N-terminus, and secreted extracellularly. The N-terminus of the pro-enzyme has 15 repeats of 13 amino acids which provide a lysostaphin pre-enzyme source with 70% less activity than mature lysostaphin. These repeats form active lysostaphin upon degradation by secreted cysteine proteases. Mature lysostaphin molecules consist of two parts: an N-terminal protease region (PD) having protease catalytic activity; c-terminal cell wall targeting region (CWT), CWT guides lysostaphin to bind to the receptor on the surface of staphylococcus aureus, acts on Gly pentapeptide bridging in the crosslinked structure of peptidoglycan of cell wall of staphylococcus aureus, so as to crack cells and achieve the effect of wall breaking and bacteriolysis.
3. The novel disinfectant has the following advantages:
(1) The sterilization concentration is lower, and two parts per million are generally used;
(2) The product has no irritation and toxicity;
(3) The solvent has faint scent slightly, and has no corrosion and bleaching effects on the surface of an object;
(4) Broad spectrum sterilization, lasting for more than 8 hours;
(5) Stable property, light resistance, heat resistance and easy storage.
4. The novel disinfectant provided by the invention is used in the scene and market channel:
(1) The sterilizing device can be applied to environmental sterilization in unit office and enterprise production;
(2) The sterilizing agent can be applied to environmental sterilization of school places such as classrooms, dormitories, dining halls, libraries and the like;
(3) The sterilizing device can be applied to the sterilization of public transportation means such as subways, buses, taxis and the like;
(4) Can be applied to the environmental disinfection of hospitals and medical institutions;
(5) The sterilizing agent can be applied to environmental sterilization of market supermarkets, entertainment venues, amusement parks, movie theatres and the like;
(6) The method can be applied to the environment disinfection of communities and residential communities;
(7) Can be used for sterilizing household and personal, such as clothing, furniture, hand skin, etc.
5. The novel disinfectant disclosed by the invention is nontoxic, harmless, noncorrosive and biodegradable, has the advantages of high speed of killing novel coronaviruses and long duration of action, and has incomparable safety, broad spectrum and the like compared with the traditional disinfectant shown in the following table. The novel disinfectant disclosed by the invention is widely applied to the disinfection of European and American health institutions, school communities, transportation hubs, logistics storage and other scenes on the aspect of preventing novel coronaviruses of personnel, articles, facilities and the like.
Detailed Description
For a better understanding of the present invention, the following examples are now to be taken as being within the scope of the present invention, but are not to be construed as limiting the scope of the present invention.
In this embodiment, the novel disinfectant for effectively inactivating a novel coronavirus comprises the following raw materials in parts by weight: 20-32 parts of natural plant extract, 0.4-0.7 part of food-grade active agent, 2-3 parts of compound quaternary ammonium chloride compound, 0.2-0.4 part of lysostaphin, 3-5 parts of eucalyptol, 1-2 parts of hydroxypropyl starch and 58-64 parts of water;
the natural plant extract liquid comprises one or more of tea tree essential oil, uganilli essential oil, eucalyptus essential oil, juniper essential oil, grape seed extract, castor extract and hibiscus extract;
the food grade active agent comprises erucic acid;
the compound quaternary ammonium chloride compound consists of cetylpyridinium chloride, didecyl dimethyl ammonium chloride and benzalkonium chloride according to the weight ratio of 2-4:5-7:1-2;
the water comprises one or more of distilled water, purified water and fresh cool boiled water;
the preparation method of the novel disinfectant for effectively inactivating the novel coronavirus comprises the following steps:
s1: mixing natural plant extract, food-grade active agent and water, heating to 55-63deg.C, stirring at 200-300r/min for 7-10min to obtain mixed solution A;
s2: cooling the mixed solution A prepared in the step S1 to 32-45 ℃, adding a compound quaternary ammonium chloride compound, and stirring for 6-8min at the microwave power of 100-200W and the rotating speed of 300-400r/min to prepare mixed solution B;
s3: and (2) adding lysostaphin, eucalyptol and hydroxypropyl starch into the mixed solution B prepared in the step (S2), stirring for 5-6min at the temperature of 46-52 ℃ and the temperature of 200-300r/min under the pressure of 1-2MPa, and then adjusting the pH value to 6-6.8 to prepare the novel disinfectant for effectively inactivating the novel coronavirus.
The novel disinfectant for effectively inactivating the novel coronavirus is diluted to a mass concentration not lower than two parts per million by one or more of distilled water, purified water and fresh cool boiled water, and then sprayed into the air or sprayed onto the surface of an object in an atomization mode, so that the novel coronavirus can be effectively inactivated.
The following is a description of more specific examples.
Example 1
The novel disinfectant for effectively inactivating the novel coronavirus comprises the following raw materials in parts by weight: 22 parts of natural plant extract, 0.5 part of food-grade active agent, 2 parts of compound quaternary ammonium chloride compound, 0.2 part of lysostaphin, 3.4 parts of citral, 1 part of hydroxypropyl starch and 59 parts of water;
the natural plant extract contains tea tree essential oil;
the food grade active agent comprises erucic acid;
the compound quaternary ammonium chloride compound consists of cetylpyridinium chloride, didecyl dimethyl ammonium chloride and benzalkonium chloride according to the weight ratio of 2:5:1;
the water is distilled water;
the preparation method of the novel disinfectant for effectively inactivating the novel coronavirus comprises the following steps:
s1: mixing natural plant extract, food-grade active agent and water, heating to 57 ℃, and stirring at a rotation speed of 200r/min for 10min to obtain a mixed solution A;
s2: cooling the mixed solution A prepared in the step S1 to 35 ℃, adding a compound quaternary ammonium chloride compound, and stirring for 8min at the microwave power of 100W and the rotating speed of 300r/min to prepare a mixed solution B;
s3: and (2) adding lysostaphin, eucalyptol and hydroxypropyl starch into the mixed solution B prepared in the step (S2), stirring for 6min at 48 ℃ under the pressure of 1MPa and the rotation speed of 200r/min, and then adjusting the pH value to 6.2 to obtain the novel disinfectant for effectively inactivating the novel coronavirus.
Example 2
The novel disinfectant for effectively inactivating the novel coronavirus comprises the following raw materials in parts by weight: 28 parts of natural plant extract, 0.6 part of food-grade active agent, 2.4 parts of compound quaternary ammonium chloride compound, 0.3 part of lysostaphin, 4 parts of eucalyptol, 1.6 parts of hydroxypropyl starch and 60 parts of water;
the natural plant extract liquid contains a castor extract and a cottonrose hibiscus extract, wherein the weight ratio of the castor extract to the cottonrose hibiscus extract is 4:3;
the food grade active agent comprises erucic acid;
the compound quaternary ammonium chloride compound consists of cetylpyridinium chloride, didecyl dimethyl ammonium chloride and benzalkonium chloride according to the weight ratio of 3:6.2:1.4;
the water is purified water;
the preparation method of the novel disinfectant for effectively inactivating the novel coronavirus comprises the following steps:
s1: mixing natural plant extract, food-grade active agent and water, heating to 60deg.C, and stirring at 300r/min for 7min to obtain mixed solution A;
s2: cooling the mixed solution A prepared in the step S1 to 42 ℃, adding a compound quaternary ammonium chloride compound, and stirring for 6min at the microwave power of 200W and the rotating speed of 400r/min to prepare a mixed solution B;
s3: and (2) adding lysostaphin, eucalyptol and hydroxypropyl starch into the mixed solution B prepared in the step (S2), stirring for 5min at the temperature of 50 ℃ and the pressure of 1.6MPa and the rotating speed of 300r/min, and then adjusting the pH value to 6.5 to prepare the novel disinfectant for effectively inactivating the novel coronavirus.
Example 3
The novel disinfectant for effectively inactivating the novel coronavirus comprises the following raw materials in parts by weight: 30 parts of natural plant extract, 0.7 part of food-grade active agent, 2.9 parts of compound quaternary ammonium chloride compound, 0.4 part of lysostaphin, 4.8 parts of citral, 1.7 parts of hydroxypropyl starch and 63 parts of water;
the natural plant extract contains grape seed extract;
the food grade active agent comprises erucic acid;
the compound quaternary ammonium chloride compound consists of cetylpyridinium chloride, didecyl dimethyl ammonium chloride and benzalkonium chloride according to the weight ratio of 4:7:2;
the water is fresh cool boiled water;
the preparation method of the novel disinfectant for effectively inactivating the novel coronavirus comprises the following steps:
s1: mixing natural plant extract, food-grade active agent and water, heating to 62deg.C, and stirring at 300r/min for 7min to obtain mixed solution A;
s2: cooling the mixed solution A prepared in the step S1 to 44 ℃, adding a compound quaternary ammonium chloride compound, and stirring for 7min at the microwave power of 160W and the rotating speed of 400r/min to prepare a mixed solution B;
s3: and (2) adding lysostaphin, eucalyptol and hydroxypropyl starch into the mixed solution B prepared in the step (S2), stirring for 6min at the temperature of 47 ℃ and the rotation speed of 200r/min under the pressure of 2MPa, and then adjusting the pH value to 6.7 to obtain the novel disinfectant for effectively inactivating the novel coronavirus.
Comparative example 1
The process was essentially the same as that of example 2, except that the novel disinfectant was prepared lacking lysostaphin, eucalyptol and hydroxypropyl starch as raw materials.
Comparative example 2
The process was essentially the same as that of example 2, except that the novel disinfectant was prepared with the exception that lysostaphin was absent from the starting material.
Comparative example 3
The process was essentially the same as that of example 2, except that the novel disinfectant was prepared with the lack of eucalyptol as the starting material.
Comparative example 4
The process was essentially the same as that of example 2, except that the novel disinfectant was prepared with the lack of hydroxypropyl starch as the starting material.
Test for inactivation of novel coronaviruses in vitro by disinfectant
1. Purpose of test
The disinfectant was tested for its inactivating effect on the novel coronavirus SARS-CoV-2.
2. Material
(1) Test sample
Disinfectants prepared in examples 1-3 and comparative examples 1-4.
(2) Cells
Vero cells were obtained from ATCC in the united states and cultured in MEM medium (Invitrogen) containing 10% fbs. Vero cells were counted after digestion with pancreatin digest and cell concentrations were adjusted to 2×10 with MEM medium containing 2% fbs 5 /mL。
(3) Virus (virus)
The novel coronavirus is obtained by inoculating Vero cells to sputum samples from patients with clinical acute stage of novel coronapneumonia, is determined to be novel coronavirus by fluorescence PCR (Cat No. Z-RR-0479, national mechanical injection 20203400057, shanghai river Biotechnology Co., ltd.) and viral whole gene sequencing (GSAID, hCoV-19/Hangzhou/ZJU-05/2020Vero EPI_ISL_415711), and other respiratory viruses are excluded from the culture by fluorescence PCR. Virus titres were determined by cytopathic observations and diluted to 2X 10 6 TCID 50 /mL。
3. Method and results
(1) Method for testing inactivation of disinfectant on new coronavirus
In the sterile 7 sample tubes, marks 1-7 respectively, adds the diluted disinfectants prepared in examples 1-3 and comparative examples 1-4 respectively (all adopt purified water to dilute the disinfectants to the mass concentration of two parts per million) to 100uL, then adds 2X 106 TCID50/mL of new coronavirus liquid 10uL into the corresponding marked sample tubes respectively, mixes gently and incubates at room temperature for 15min. After a predetermined time point of action, the disinfectant/virus mixture was transferred to 6-well cell cultureInto the plates, 4mL of Vero cell suspension (2X 10) was added immediately 5 /mL), placed in CO 2 The incubator continues to incubate for 72 hours.
(2) Novel coronavirus nucleic acid detection in culture solution
The real-time fluorescence quantitative PCR method is adopted. 200. Mu.L of the cell culture supernatant was aspirated, and viral nucleic acid was extracted with a magnetic bead nucleic acid extraction kit (MVR 01) and a full-automatic nucleic acid extractor (EX 3600, shanghai, river Biotechnology Co., ltd.) to give a final elution volume of 50. Mu.L. Taking 5 mu L of nucleic acid extract, adopting a novel coronavirus nucleic acid detection kit (fluorescent PCR method, product number Z-RR-0479, national standard 20203400057, shanghai river Biotechnology Co., ltd.) by a one-step method to detect the level of virus nucleic acid, and calculating the inhibition or inactivation efficiency of a sample to be detected on the virus according to the Ct value. [ Ct= -3.33Log 10 C(copies/mL)+42.03]. The results are shown in the following table.
Remarks: the above experiments involving live virus manipulation were all performed in the biosafety tertiary laboratory (BSL-3).
4. Conclusion analysis
From the above table, it can be seen that: (1) After the disinfectant prepared in the examples 1-3 is diluted to the mass concentration of two parts per million, the novel coronavirus SARS-CoV-2 can be effectively inactivated within 15 minutes, and the inactivation efficiency is more than 99.9%.
(2) From the inactivation efficiency data of the novel coronaviruses of example 2 and comparative examples 1-4, it can be calculated that the effect value of the inactivation efficiency of the novel coronaviruses produced when lysostaphin, eucalyptol citrate and hydroxypropyl starch are used together is improved by a percentage=15.02% > 10% compared with the effect value of the inactivation efficiency of the novel coronaviruses produced by superposition of lysostaphin, eucalyptol citrate and hydroxypropyl starch when the lysostaphin, eucalyptol citrate and hydroxypropyl starch are used separately, respectively, because the improved percentage is more than 10%, it is explained that the lysostaphin, eucalyptol and hydroxypropyl starch play a synergistic effect in preparing the novel disinfectant, and the inactivation efficiency of the novel coronaviruses is synergistically improved, because:
the lysostaphin can interfere with the normal function of the novel coronavirus to cause the nutrient loss of the novel coronavirus and further cause the gradual death of the novel coronavirus, and the novel coronavirus is matched with the citrinol for use, so that the citrinol can form a supermolecular stable structure with the lysostaphin, and the stability and the lasting virucidal effect of the novel disinfectant are further improved; meanwhile, the eucalyptol has extremely strong virucidal capability, can change the potential of the virus surface, can enhance the penetration capability of lysostaphin, and further enhances the virucidal effect; the hydroxypropyl starch has good viscosity, and after the novel disinfectant disclosed by the invention is used, the novel disinfectant can be adhered to the surface of a novel coronavirus, so that interaction between the eucalyptol citrate and the lysostaphin is promoted, the lasting virucidal effect is enhanced, and the inactivation efficiency of the novel coronavirus is improved.
The above description should not be taken as limiting the practice of the invention to these descriptions, but it will be understood by those skilled in the art that several simple deductions or substitutions may be made without departing from the spirit of the invention, and the invention is defined by the appended claims.
Claims (7)
1. The disinfectant for effectively inactivating the novel coronavirus is characterized by comprising the following raw materials in parts by weight: 20-32 parts of natural plant extract, 0.4-0.7 part of food-grade active agent, 2-3 parts of compound quaternary ammonium chloride compound, 0.2-0.4 part of lysostaphin, 3-5 parts of eucalyptol, 1-2 parts of hydroxypropyl starch and 58-64 parts of water;
the natural plant extract liquid comprises one or more of tea tree essential oil, grape seed extract, castor extract and cottonrose hibiscus extract;
the food grade active agent comprises erucic acid;
the compound quaternary ammonium chloride compound consists of cetylpyridinium chloride, didecyl dimethyl ammonium chloride and benzalkonium chloride according to the weight ratio of 2-4:5-7:1-2.
2. The disinfectant for effectively inactivating novel coronaviruses according to claim 1, comprising the following raw materials in parts by weight: 28 parts of natural plant extract, 0.6 part of food-grade active agent, 2.4 parts of compound quaternary ammonium chloride compound, 0.3 part of lysostaphin, 4 parts of eucalyptol, 1.6 parts of hydroxypropyl starch and 60 parts of water.
3. The disinfectant for effectively inactivating novel coronaviruses according to claim 1, wherein the compound quaternary ammonium chloride compound consists of cetylpyridinium chloride, didecyl dimethyl ammonium chloride and benzalkonium chloride in a weight ratio of 3:6.2:1.4.
4. The disinfectant effective to inactivate a novel coronavirus according to claim 1, wherein the water comprises one or more of distilled water, purified water, fresh cool boiled water.
5. A method of preparing a disinfectant effective to inactivate a novel coronavirus according to any one of claims 1-4 comprising the steps of:
s1: mixing natural plant extract, food-grade active agent and water, heating to 55-63deg.C, stirring at 200-300r/min for 7-10min to obtain mixed solution A;
s2: cooling the mixed solution A prepared in the step S1 to 32-45 ℃, adding a compound quaternary ammonium chloride compound, and stirring for 6-8min at the microwave power of 100-200W and the rotating speed of 300-400r/min to prepare mixed solution B;
s3: and (2) adding lysostaphin, eucalyptol and hydroxypropyl starch into the mixed solution B prepared in the step (S2), stirring for 5-6min at the temperature of 46-52 ℃ and the temperature of 200-300r/min under the pressure of 1-2MPa, and then regulating the pH value to obtain the disinfectant for effectively inactivating the novel coronavirus.
6. The method of claim 5, wherein the pH in step S3 is 6-6.8.
7. A method of using the disinfectant for effectively inactivating a novel coronavirus prepared by the method of claim 5 or 6, wherein the disinfectant is diluted to a mass concentration of not less than two parts per million by one or more of distilled water, purified water and fresh cool boiled water, and then sprayed into the air or onto the surface of an object by an atomization method, thereby effectively inactivating the novel coronavirus.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110810090.0A CN115363058B (en) | 2021-07-18 | 2021-07-18 | Disinfectant for effectively inactivating novel coronaviruses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110810090.0A CN115363058B (en) | 2021-07-18 | 2021-07-18 | Disinfectant for effectively inactivating novel coronaviruses |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115363058A CN115363058A (en) | 2022-11-22 |
CN115363058B true CN115363058B (en) | 2024-03-22 |
Family
ID=84060536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110810090.0A Active CN115363058B (en) | 2021-07-18 | 2021-07-18 | Disinfectant for effectively inactivating novel coronaviruses |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115363058B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116058388A (en) * | 2023-02-01 | 2023-05-05 | 徐宝华 | Composition capable of sterilizing and inhibiting viruses and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104524557A (en) * | 2014-12-16 | 2015-04-22 | 杨陈 | Lysostaphin compound disinfection gel |
CN107198769A (en) * | 2017-05-04 | 2017-09-26 | 艾伯尔生物科技(重庆)有限公司 | Oral disinfecting spray and preparation method thereof |
CN107208042A (en) * | 2014-09-17 | 2017-09-26 | 斯波根生物技术公司 | Fusion protein, recombinant bacteria and the method using recombinant bacteria |
US10426740B1 (en) * | 2010-08-18 | 2019-10-01 | Avm Biotechnology, Llc | Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
CN111903709A (en) * | 2020-08-11 | 2020-11-10 | 北京锦绣新技术发展有限公司 | Preparation method of sterilizing disinfectant for killing coronavirus |
CN112618525A (en) * | 2020-12-18 | 2021-04-09 | 上海海禾医疗科技有限公司 | Disinfectant for quickly inactivating coronavirus |
-
2021
- 2021-07-18 CN CN202110810090.0A patent/CN115363058B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10426740B1 (en) * | 2010-08-18 | 2019-10-01 | Avm Biotechnology, Llc | Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
CN107208042A (en) * | 2014-09-17 | 2017-09-26 | 斯波根生物技术公司 | Fusion protein, recombinant bacteria and the method using recombinant bacteria |
CN104524557A (en) * | 2014-12-16 | 2015-04-22 | 杨陈 | Lysostaphin compound disinfection gel |
CN107198769A (en) * | 2017-05-04 | 2017-09-26 | 艾伯尔生物科技(重庆)有限公司 | Oral disinfecting spray and preparation method thereof |
CN111903709A (en) * | 2020-08-11 | 2020-11-10 | 北京锦绣新技术发展有限公司 | Preparation method of sterilizing disinfectant for killing coronavirus |
CN112618525A (en) * | 2020-12-18 | 2021-04-09 | 上海海禾医疗科技有限公司 | Disinfectant for quickly inactivating coronavirus |
Also Published As
Publication number | Publication date |
---|---|
CN115363058A (en) | 2022-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wong et al. | Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus | |
CA2359627C (en) | Multi-purpose acid compositions comprising three gras acids | |
EP3351264B1 (en) | Composition comprising protease, amylase and lipase | |
US5444094A (en) | Methods and compositions for disinfecting surfaces containing tuberculosis causing bacteria | |
US20070134136A1 (en) | Disinfecting composition | |
UA53683C2 (en) | Bactericidal composition | |
KR20100031468A (en) | Anti-bacterium deodorant | |
CN115363058B (en) | Disinfectant for effectively inactivating novel coronaviruses | |
AU2011247875B1 (en) | Disinfectant Compositions and Uses Thereof | |
US20060075922A1 (en) | Controlled-acidity composition | |
CN106234439A (en) | A kind of superbacteria antibiosis and sterilization agent and its production and use | |
Phillips et al. | Chemical disinfectants | |
Motiejūnaitė et al. | Fungicidal properties of Pinus sylvestris L. for improvement of air quality | |
US4208404A (en) | Glutaraldehyde sterilizing compositions | |
CN106942258A (en) | Cationic surfactant composite disinfectant for animals and preparation method and application | |
CN105916497A (en) | Bioactive heme-haloperoxidase compositions and methods of their use | |
CN104886110A (en) | Multipurpose composite cationic surfactant type disinfectant | |
CN113317327A (en) | Bactericidal virucidal enzyme preparation composition and application thereof | |
JP2004155712A (en) | Sterilizer/disinfectant for external use | |
CN102450281A (en) | Triumph ecological guanidine treasure | |
Stolle et al. | Ozone: A Novel Sterilizer for Personal Protective Equipment | |
US11622930B2 (en) | Antimicrobial agent | |
CN108935534A (en) | Air sanitizer | |
Soni et al. | A systematic overview of metal nanoparticles as alternative disinfectants for emerging SARS-CoV-2 variants | |
Otaka et al. | High pressure pasteurization: Simultaneous native tissue decellularization and sterilization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |